Capricor Therapeutics, Inc. (CAPR)
NASDAQ: CAPR · Real-Time Price · USD
25.84
-1.02 (-3.80%)
At close: Mar 3, 2026, 4:00 PM EST
26.22
+0.38 (1.47%)
After-hours: Mar 3, 2026, 7:57 PM EST
Capricor Therapeutics Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Capricor Therapeutics stock have an average target of 41.38, with a low estimate of 13 and a high estimate of 60. The average target predicts an increase of 60.14% from the current stock price of 25.84.
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 15, 2025.
Analyst Ratings
The average analyst rating for Capricor Therapeutics stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 4 | 5 | 5 | 5 |
| Buy | 3 | 3 | 2 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 6 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $21 → $50 | Strong Buy | Reiterates | $21 → $50 | +93.50% | Dec 15, 2025 |
| Piper Sandler | Piper Sandler | Buy Reiterates $20 → $45 | Buy | Reiterates | $20 → $45 | +74.15% | Dec 10, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $22 → $54 | Buy | Maintains | $22 → $54 | +108.98% | Dec 8, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $25 → $50 | Strong Buy | Maintains | $25 → $50 | +93.50% | Dec 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $24 → $60 | Strong Buy | Maintains | $24 → $60 | +132.20% | Dec 3, 2025 |
Financial Forecast
Revenue This Year
612.00K
from 22.27M
Decreased by -97.25%
Revenue Next Year
106.54M
from 612.00K
Increased by 17,308.50%
EPS This Year
-2.20
from -1.15
EPS Next Year
-1.57
from -2.20
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 6.3M | 267.8M | ||||
| Avg | 612,000 | 106.5M | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -71.7% | 43,650.0% | ||||
| Avg | -97.3% | 17,308.5% | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -2.12 | -0.84 | ||||
| Avg | -2.20 | -1.57 | ||||
| Low | -2.19 | -2.31 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.